Frederic Maxime Vaz

Title: Frederic Maxime Vaz: Innovator in Medical Diagnostics

Introduction

Frederic Maxime Vaz is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of medical diagnostics, particularly in the area of genetic disorders. His work focuses on innovative methods that enhance the accuracy of disease detection.

Latest Patents

Frederic Maxime Vaz holds a patent for a screening method for cerebrotendinous xanthomatosis using bile alcohol glucuronides and metabolite ratios. This invention relates to a method of diagnosing or screening for 27-hydroxylase (CYP27A1) deficiency in an animal. The process involves determining the intensity signal by mass analysis of at least a bile alcohol glucuronide and a C24- or C27-bile acid or a conjugate thereof. The intensity signals are then compared to a control sample or control value, allowing for the determination of 27-hydroxylase (CYP27A1) deficiency based on this comparison. This patent showcases his innovative approach to addressing complex medical conditions.

Career Highlights

Frederic Maxime Vaz is affiliated with the Academisch Medisch Centrum, where he applies his expertise in medical research and diagnostics. His work at this institution has allowed him to collaborate with other professionals in the field, further enhancing his contributions to medical science.

Collaborations

Due to space constraints, the details of his collaborations will not be included.

Conclusion

Frederic Maxime Vaz is a pioneering inventor whose work in medical diagnostics has the potential to significantly improve the detection of genetic disorders. His innovative patent reflects his commitment to advancing healthcare through scientific research and development.